Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GPC2 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-11 |
mRNA | TUBA1A | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-11 |
mRNA | CAMK2N2 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-11 |
mRNA | DOK6 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-11 |
mRNA | ACTL6B | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-11 |
mRNA | TAGLN3 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-11 |
mRNA | CBFA2T2 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-11 |
mRNA | STXBP5L | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-11 |
mRNA | SOX4 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-11 |
mRNA | ZNF428 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-11 |